Literature DB >> 24648550

Bioterrorism: a laboratory who does it?

David W Craft1, Philip A Lee2, Marie-Claire Rowlinson2.   

Abstract

In October 2001, the first disseminated biological warfare attack was perpetrated on American soil. Initially, a few clinical microbiology laboratories were testing specimens from acutely ill patients and also being asked to test nasal swabs from the potentially exposed. Soon after, a significant number of clinical microbiology and public health laboratories received similar requests to test the worried well or evaluate potentially contaminated mail or environmental materials, sometimes from their own break rooms. The role of the clinical and public health microbiology laboratory in response to a select agent event or act of bioterrorism is reviewed.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24648550      PMCID: PMC4097698          DOI: 10.1128/JCM.00359-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Bioterrorism: implications for the clinical microbiologist.

Authors:  W F Klietmann; K L Ruoff
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-04-21

3.  Bioterrorism readiness plan--a template for healthcare facilities. Association for Professionals in Infection Control and Epidemiology Inc. and Centers for Disease Control and Prevention.

Authors: 
Journal:  ED Manag       Date:  1999-11

4.  Index case of fatal inhalational anthrax due to bioterrorism in the United States.

Authors:  L M Bush; B H Abrams; A Beall; C C Johnson
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

5.  Core functions and capabilities of state public health laboratories: a report of the Association of Public Health Laboratories.

Authors:  Joyce Witt-Kushner; J Rex Astles; John C Ridderhof; Robert A Martin; Burton Wilcke; Frances P Downes; Stanley L Inhorn; H Peter Kelley; Paul B Kimsey; David E Mills; Max Salfinger; Peter A Shult; Mahadeo P Verma; Scott J Becker; Doug J Drabkowski
Journal:  MMWR Recomm Rep       Date:  2002-09-20

6.  Destroying the life and career of a valued physician-scientist who tried to protect us from plague: was it really necessary?

Authors:  Barbara E Murray; Karl E Anderson; Keith Arnold; John G Bartlett; Charles C Carpenter; Stanley Falkow; J Ted Hartman; Tom Lehman; Ted W Reid; Frank M Ryburn; R Bradley Sack; Marc J Struelens; Lowell S Young; William B Greenough
Journal:  Clin Infect Dis       Date:  2005-04-29       Impact factor: 9.079

Review 7.  Clinical recognition and management of patients exposed to biological warfare agents.

Authors:  D R Franz; P B Jahrling; A M Friedlander; D J McClain; D L Hoover; W R Bryne; J A Pavlin; G W Christopher; E M Eitzen
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

8.  Biological warfare. A historical perspective.

Authors:  G W Christopher; T J Cieslak; J A Pavlin; E M Eitzen
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

9.  Death due to bioterrorism-related inhalational anthrax: report of 2 patients.

Authors:  L Borio; D Frank; V Mani; C Chiriboga; M Pollanen; M Ripple; S Ali; C DiAngelo; J Lee; J Arden; J Titus; D Fowler; T O'Toole; H Masur; J Bartlett; T Inglesby
Journal:  JAMA       Date:  2001-11-28       Impact factor: 56.272

10.  Public health assessment of potential biological terrorism agents.

Authors:  Lisa D Rotz; Ali S Khan; Scott R Lillibridge; Stephen M Ostroff; James M Hughes
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  1 in total

1.  Identification of an unauthorized genetically modified bacteria in food enzyme through whole-genome sequencing.

Authors:  Marie-Alice Fraiture; Bert Bogaerts; Raf Winand; Marie Deckers; Nina Papazova; Kevin Vanneste; Sigrid C J De Keersmaecker; Nancy H C Roosens
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.